Otrivin Child Moisturising

Go To

Woman nasal spray

Unblocks your child’s nose quickly, within a matter of minutes1

Otrivin Original Child nasal spray is specially formulated to unblock children’s noses rapidly and is designed specifically for children aged between 1 and 11 years old.1

Decongestion of the nasal mucosa and neighbouring tissues of the pharynx improves nasal airflow.1,2

Woman smelling flowers

Rapid relief and long-lasting nasal decongestion1 with soothing and moisturising benefits

Otrivin Original Child contains xylometazoline, a topical decongestant that acts locally on the nasal mucosa.

  • Relief is rapid – within a matter of 2-5 minutes, rather than up to half an hour for oral decongestants2
  • It provides a longer duration of action – up to 12 hours; oral decongestants only last for half that time2

The addition of sorbitol and hypromellose soothes and moisturises dry and irritated nasal passageways.3,4

Sorbitol-and-Hypromellose

Otrivin Original Child is formulated with xylometazoline for fast decongestion, and hypromellose + sorbitol for moisturisation.

Read more

Recommend Otrivin Original Child nasal spray to your patients for rapid decongestion and protection from dryness of the nose

Otrivin child original packshot

Original Child pack shot

Otrivin Original Child nasal spray (0.05% xylometazoline with hypromellose + sorbitol)

Otrivin Original Child product details

  • Active ingredients:4

    • Otrivin 0.05% nasal solutions contain 0.5 mg/mL of xylometazoline hydrochloride.

  • Dosing instructions:4

    Otrivin (0.05%) nasal spray:

    Children Under 1 year of age: should NOT use the product Children between 1 and 2 years old: only use as prescribed by a doctor Children between 2 and 11 years old: only use under adult supervision

    • 1 spray puff with the 0.05% metered-dose
    • Spray 1-2 times a day in each nostril are usually sufficient
    • Do not exceed 3 applications per day
    • Do not use continuously for more than 7 consecutive days
    • If cold symptoms persist, consult your doctor or pharmacist

    How to use:4

    Drops:

    • Clear the nose
    • Tilt the head back as far as is comfortable or, if lying on a bed, hang the head over the side
    • Apply the drops into each nostril and keep the head tilted back for a short time, to allow the drops to spread throughout the nose
    • Clean and dry the dropper before replacing it in the bottle immediately after use
    • To avoid possible spread of infection, the bottle should only be used by one person

    Metered Spray:

    • Before using for the first time, the pump should be primed by performing a few pumping motions until an even spray is released into the air. At subsequent applications, the dosing spray pump will be ready for instant use
    • Each metered-dose spray of Otrivin 0.05% delivers 0.07 ml per actuation (0.035 mg of xylometazoline hydrochloride)
    • Each metered-dose spray of Otrivin 0.1% delivers 0.14 ml per actuation (0.14 mg of xylometazoline hydrochloride)
    • Clear the nose
    • Hold the bottle upright with your thumb under the base and the nozzle between two fingers
    • Lean forward slightly and insert the nozzle into a nostril
    • Spray and breathe in gently through the nose at the same time before repeating in the other nostril
    • Clean and dry the nozzle before replacing the cap immediately after use
    • To avoid possible spread of infection, the spray should only be used by one person

    Spray:

    • Be careful not to spray in the eyes.
    • Clear the nose.
    • Lean forward slightly and insert the nozzle into a nostril.
    • Squeeze the bottle once and breathe in gently at the same time.
    • Remove the nozzle before releasing the pressure on the bottle.
    • Clean and dry the nozzle before replacing back the cap right after use.
    • To avoid possible spread of infection, the spray should only be used by one person.

    • Xylometazoline, like other sympathomimetic agents, should be used with caution in patients showing a strong reaction to adrenergic substances, as manifested by signs of insomnia, dizziness, tremors, cardiac arrhythmia, or elevated blood pressure
    • Otrivin Moisturising should be used with caution in patients with hypertension, cardiovascular disease, hyperthyroidism, diabetes mellitus, phaeochromocytoma, prostatic hypertrophy, monoamine oxidase inhibitors (MAOI) treatment, or who have received them in the last two weeks
    • As with other topical vasoconstrictors, it should not be used for more than 10 consecutive days; prolonged or excessive use may cause rebound congestion and/or atrophy of the nasal mucosa
    • Keep out of sight and reach of children

Otrivin – your Nasal Health Partner

Otrivin logo

The Otrivin range

Find out how the Otrivin range can help your patients.

Find out more

Patient care resources icon

Register Now

Join the Community

Register now

Patient care resources icon

Patient care resources

Download resources for your patients.

Find out more